• share
• favorite_border

Transformative research offering fresh insights and treatment advancements for age-related macular degeneration (AMD), the leading cause of blindness in adults over age 50, will be among the highlights showcased from May 4 - 8 at the Association for Research in Vision and Ophthalmology鈥檚 (ARVO) 2025 Annual Meeting in Salt Lake City, Utah.

• share
• favorite_border

From May 4 - 8,聽more than 8,000 scientists will gather at the Association for Research in Vision and Ophthalmology鈥檚 (ARVO) 2025 Annual Meeting in Salt Lake City, Utah, to share the latest discoveries in eye and vision research. Many studies being presented focus on the retina, the light-sensitive tissue at the back of the eye that captures the images people see and sends signals to the brain so that people can see and understand the world around them.

• share
• favorite_border

鈥� Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors 鈥� One patient experienced a complete response, and one patient had a partial response 鈥� This type of cancer has limited treatment options, and most patients have a poor prognosis of six months or less 鈥� AIC100 is a CAR T cell therapy that targets the ICAM-1 protein on tumor cells

• share
• favorite_border

鈥� Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer

• share
• favorite_border

Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in identifying nonmelanoma skin cancers (NMSC) from digital images of tissue samples, according to research presented at the American Association for Cancer Research (AACR) Annual Meeting, held April 25-30.

• share
• favorite_border

鈥� RO7589831, a new drug from Roche, is first in a new class of drugs called Werner helicase inhibitors 鈥� Drug works similarly to other DNA damage repair inhibitors, such as PARP inhibitors 鈥� This class of drugs is important because many solid tumor patients with microsatellite instability (MSI) do not benefit from currently approved immunotherapies 鈥� Encouraging early results in this first-in-human trial prompted additional trial cohorts to optimize recommended dose for future clinical development

• share
• favorite_border

UCLA researchers demonstrated that a novel topical BRAF inhibitor gel called LUT014 significantly reduces the severity of an acne-like rash, a common and painful side effect experienced by patients undergoing anti-EGFR therapies for colorectal cancer.

• share
• favorite_border

New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), demonstrate how immunotherapy alone can allow people with MMRd cancers to avoid surgery and preserve their quality of life. The results, presented at the 2025 American Association of Cancer Research (AACR) Annual Meeting and published simultaneously in The New England Journal of Medicine (NEJM), found that 80 percent of patients did not require surgery, radiation, or chemotherapy after six months of treatment with immunotherapy alone.

• share
• favorite_border

An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis and Dana-Farber Brigham Cancer Center shows that patients with certain locally advanced head and neck cancers benefited from the addition of the immunotherapy drug pembrolizumab (brand name Keytruda) to standard-of-care therapy. Patients who received pembrolizumab saw greater tumor shrinkage prior to surgery and, on average, survived cancer-free almost two years longer than did patients who only received standard-of-care therapy.

• share
• favorite_border

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without the cancer coming back and higher rates of substantial tumor shrinkage prior to surgery, according to the first interim analysis of a randomized, open-label phase 3 clinical trial led by investigators from Dana-Farber Brigham Cancer Center and Washington University School of Medicine in St. Louis.

• share
• favorite_border

Ludwig Cancer Research is proud to support eight early-career scientists presenting their research at the conference this year through the AACR Scholar-in-Training Awards (SITA) program, contributing to the cost of their travel and attendance at the conference.

• share
• favorite_border

Ludwig Cancer Research released today the full scope of research to be presented by Ludwig-affiliated scientists at the American Association for Cancer Research (AACR) Annual Meeting 2025, which will be held online and in person in Chicago, from April 25 to April 30.

• share
• favorite_border

A new targeted drug treatment for small cell lung cancer, understanding how obesity drives endometrial cancer, and predicting early-stage melanoma spread are among the research topics being presented by scientists with The Ohio State University Comprehensive Cancer Center 鈥� Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at the American Association for Cancer Research Annual Meeting April 25-30 in Chicago.

• share
• favorite_border

A woman smashed a longstanding world record in the 200-meter sprint at the age of 91, prompting scientists to delve into her physiology to learn how she can run so fast. Researchers will present their findings at the 2025 American Physiology Summit in Baltimore. The Summit is the flagship annual meeting of the American Physiological Society (APS).

• share
• favorite_border

A study conducted in mice suggests that daily exercise could help to counteract some of the negative impacts of college-age drinking later in life.

• share
• favorite_border

Erythritol, a commonly used sugar substitute often marketed as 鈥渉ealthy,鈥� may impair blood vessel health by disrupting the brain鈥檚 ability to produce a critical compound, according to new research. Scientists will present their findings at the 2025 American Physiology Summit in Baltimore. The Summit is the flagship annual meeting of the American Physiological Society (APS).

• share
• favorite_border

Simply watching virtual reality (VR) scenes of a warm environment during exercise may influence physiologic processes that control body temperature. Early findings suggest that viewing hot scenes increases sweating, helping the body cool down more efficiently during exercise. Researchers will present their findings at the 2025 American Physiology Summit in Baltimore. The Summit is the flagship annual meeting of the American Physiological Society (APS).

• share
• favorite_border

New research suggests that lycopene, which gives fruits like tomatoes and watermelons their bright red color, supports healthy liver functioning and may help prevent weight gain.

• share
• favorite_border

Despite clear health warnings, many Americans have a hard time shaking the salt habit. New research suggests that consuming more potassium could help salt-lovers dodge some of the dangers.